47 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
consultant to create and execute the company’s investor relations strategy within Canada.
Ms. Cameron is a life sciences capital markets expert with over 13
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am
of European Clinical and Regulatory Affairs expert, Dr. Petra Goessens-Rueck, as Head of Clinical and Regulatory Affairs.
Dr. Petra Goessens-Rueck
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
NEWS RELEASE
RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan)
Professor Tsukasa Kumai
6-K
REPCF
Replicel Life Sciences Inc.
15 Jun 06
Current report (foreign)
12:00am
to Vancouver, B.C. and worked 3 years with Placer Dome Inc. as a Geostatistician and in-house expert consultant. For the passed 9 years, Mr. Hitchborn
6-K
EX-99.5
tnizcgk u32f0nc9ck
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
20-F/A
qefmt2955t dj
7 Sep 07
Annual report (foreign) (amended)
12:00am
20-F/A
6sm4n
23 Aug 07
Annual report (foreign) (amended)
12:00am
20-F/A
k2q704
11 Mar 09
Annual report (foreign) (amended)
12:00am
6-K
7u626it4z7zdfjwo5
21 Sep 06
Current report (foreign)
12:00am
20-F/A
5p2eg
3 Jul 08
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
dximdwrp8ti4
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm